Clinical Trial: Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers
Clinical Trial: Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck CancersSponsor and Collaborators
Stanford University
Contact
Contact: Brindha Bavan
(650) 725-4777
brindhas@stanford.edu
Principal Investigator
Daniel T Chang Stanford University
ClinicalTrials.gov Identifier
NCT01163487
